您的购物车当前为空
别名 His121 ARG57
MAGL-IN-4 (His121 ARG57) 是选择性的、口服有效的、可透过血脑屏障的、可逆的单酰基甘油脂肪酶抑制剂,IC50=6.2 nM。它主要通过大脑中选择性抑制 MAGL 增加 2-花生四烯酰甘油水平来增强内源性大麻素信号。


为众多的药物研发团队赋能,
让新药发现更简单!
MAGL-IN-4 (His121 ARG57) 是选择性的、口服有效的、可透过血脑屏障的、可逆的单酰基甘油脂肪酶抑制剂,IC50=6.2 nM。它主要通过大脑中选择性抑制 MAGL 增加 2-花生四烯酰甘油水平来增强内源性大麻素信号。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,450 | 现货 | |
| 5 mg | ¥ 3,480 | 现货 | |
| 10 mg | ¥ 4,850 | 现货 | |
| 25 mg | ¥ 7,390 | 现货 | |
| 50 mg | ¥ 9,800 | 现货 | |
| 100 mg | ¥ 13,300 | 现货 | |
| 200 mg | ¥ 17,900 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,790 | 现货 |
MAGL-IN-4 相关产品
| 产品描述 | MAGL-IN-4 (His121 ARG57) is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases. |
| 靶点活性 | MAGL:6.2 nM |
| 体外活性 | MAGL-IN-4 showed potent in vitro MAGL inhibitory activity (IC50 6.2 nM), good oral absorption and blood-brain barrier penetration[1]. |
| 体内活性 | MAGL-IN-4 showed significant pharmacodynamic changes (2-arachidonoylglycerol increase and arachidonic acid decrease) at 0.3-10 mg/kg, po. in mice[1]. |
| 别名 | His121 ARG57 |
| 分子量 | 364.82 |
| 分子式 | C18H21ClN2O4 |
| CAS No. | 2135785-20-3 |
| Smiles | Cc1ccc(COC2CN(C2)C(=O)[C@H]2C[C@@]3(C2)COC(=O)N3)cc1Cl |
| 密度 | 1.38 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 88 mg/mL (241.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.05 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容